Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 63 entries
View as:

A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine

Phase: N/A Priority: Normal
NCT ID: NCT00472303 Org: User:
Start: 07/31/07 End: 06/30/12 Due: 06/30/13

Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With Fibromyalgia

Phase: N/A Priority: Normal
NCT ID: NCT03783910 Org: User:
Start: 09/19/05 End: 10/20/06 Due: 10/20/07

Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative Pain

Phase: N/A Priority: Normal
NCT ID: NCT01729728 Org: User:
Start: 11/30/12 End: 02/28/14 Due: 02/28/15

Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol Acetate

Phase: N/A Priority: Normal
NCT ID: NCT03749733 Org: User:
Start: 10/31/19 End: 12/31/19 Due: 12/31/20

Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative Pain

Phase: N/A Priority: Normal
NCT ID: NCT01155986 Org: User:
Start: 08/31/10 End: 11/30/12 Due: 11/30/13

Efficacy and Safety of Topical Versus Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT00414349 Org: User:
Start: 12/31/06 End: 03/31/08 Due: 03/31/09

Acceptance of Clarithromycin in a Straw Compared to Syrup in Children With Upper Respiratory Tract Infections

Phase: N/A Priority: Normal
NCT ID: NCT04016051 Org: User:
Start: 09/22/04 End: 12/23/04 Due: 12/23/05

Tramadol/Diclofenac Fixed-dose Combination Phase III Trial in Acute Pain After Third Molar Extraction

Phase: N/A Priority: Normal
NCT ID: NCT03714672 Org: User:
Start: 08/26/17 End: 03/22/18 Due: 03/22/19

A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia

Phase: N/A Priority: Normal
NCT ID: NCT03765697 Org: User:
Start: 07/16/03 End: 02/12/09 Due: 02/12/10

A Study to Look at Tapentadol Oral Solution in Children and Adolescents in Pain

Phase: N/A Priority: Normal
NCT ID: NCT02081391 Org: User:
Start: 02/19/15 End: 03/14/19 Due: 03/14/20

A Study to Evaluate the Efficacy and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain After Abdominal Hysterectomy

Phase: N/A Priority: Normal
NCT ID: NCT00478023 Org: User:
Start: 05/31/07 End: 04/30/08 Due: 04/30/09

A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y

Phase: N/A Priority: Normal
NCT ID: NCT01056315 Org: User:
Start: 11/30/09 End: 01/31/11 Due: 01/31/12

Bioequivalence Trial of a New Opioid Combination Compared to Reference

Phase: N/A Priority: Normal
NCT ID: NCT00460785 Org: User:
Start: 02/28/07 End: 03/31/07 Due: 03/31/08

Efficacy and Safety of EN3324 (Axomadol) in Subjects With Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT01043263 Org: User:
Start: 12/31/09 End: 06/30/11 Due: 06/30/12

Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID: 855509)

Phase: N/A Priority: Normal
NCT ID: NCT00469053 Org: User:
Start: 05/31/07 End: 11/30/07 Due: 11/30/08

Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I

Phase: N/A Priority: Normal
NCT ID: NCT02402530 Org: User:
Start: 04/30/15 End: 11/30/16 Due: 11/30/17

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GRT9906 Prolonged Release Tablets After Dose Escalation in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03776110 Org: User:
Start: 09/15/04 End: 03/23/05 Due: 03/23/06

A Study to Evaluate the Efficacy and Safety of CG5503 Prolonged Release (PR) in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT00486811 Org: User:
Start: 06/30/07 End: 07/31/08 Due: 07/31/09

Drug-drug Interaction Study to Evaluate the Effect of Omeprazole on CG5503 (Tapentadol)

Phase: N/A Priority: Normal
NCT ID: NCT03979989 Org: User:
Start: 09/28/05 End: 11/16/05 Due: 11/16/06

Clinical Pilot Study in Healthy Men to Characterize the Uptake of Buprenorphine Into and Its Elimination From the Body After Topical Application of Two New Forms of a Skin Patch in Comparison to a Reference Patch

Phase: N/A Priority: Normal
NCT ID: NCT03785613 Org: User:
Start: 11/07/05 End: 03/14/06 Due: 03/14/07

Pharmacokinetic Characterization of Two Novel CG5503 Tablet Formulations in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03956134 Org: User:
Start: 04/30/05 End: 06/30/05 Due: 06/30/06

Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations

Phase: N/A Priority: Normal
NCT ID: NCT00387777 Org: User:
Start: 10/31/06 End: 12/31/06 Due: 12/31/07

A Clinical Study in Healthy Adults Who Sometimes Take Drugs for Pleasure Which Aims to Evaluate Whether GRT0151Y is Likely to be Abused

Phase: N/A Priority: Normal
NCT ID: NCT03768024 Org: User:
Start: 06/21/07 End: 10/25/07 Due: 10/25/08

Use of Tapentadol Oral Solution for Pain After Surgery in Children From Newborn to Less Than 2 Years Old

Phase: N/A Priority: Normal
NCT ID: NCT02221674 Org: User:
Start: 11/05/14 End: 11/03/16 Due: 11/03/17

A Clinical Study in Healthy Adults Who Sometimes Take Drugs for Pleasure to Investigate the Safety and Tolerability of GRT0151Y and to Find Out Which Single Dose of the Compound is Maximally Tolerated

Phase: N/A Priority: Normal
NCT ID: NCT03765658 Org: User:
Start: 01/20/06 End: 03/02/06 Due: 03/02/07